Skip to content

Clinical trials

Intracranial Aneurysm trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Intracranial Aneurysm Phase: Not applicable Clear all

149 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20061
20071
20083
20091
20103
20114
20128
20138
20147
20157
201610
20174
20184
20194
20208
202110
202210
202318
20247
202512
202615

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed52
Unknown status37
Recruiting24
Not yet recruiting11
Active, not recruiting10
Terminated8
Withdrawn6
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Centre hospitalier de l'Université de Montréal (CHUM)8
Medtronic Neurovascular Clinical Affairs6
MicroPort NeuroTech Co., Ltd.6
Ton-Bridge Medical Tech. Co., Ltd5
Beijing Tiantan Hospital4
Cerus Endovascular, Inc.4
Microvention-Terumo, Inc.4
Stryker Neurovascular4
Evasc Medical Systems Corp.3
Penumbra Inc.3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Intracranial Aneurysm149
Aneurysm30
Subarachnoid Hemorrhage11
Brain Diseases7
Vascular Diseases6
Aneurysm, Ruptured5
Cardiovascular Diseases5
Cerebrovascular Disorders5
Intracranial Arterial Diseases5
Central Nervous System Diseases4

Trials

Showing 26 to 50 of 149. Each trial links to its page on Pharma Observatory.

49 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.